Condition
Smoldering Multiple Myeloma (SMM) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Smoldering Multiple Myeloma (SMM) clinical trials that are recruiting, at sites in 7 countries (most in Italy (3), United States (2), Belgium (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest Smoldering Multiple Myeloma (SMM) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Multi-omics profiling to predict progression from MGUS and smoldering myeloma to symptomatic multiple myeloma | — | Bologna and 3 other locations | Recruiting | Oct 9, 2025 |
| Plant-based, high-fiber diets and the gut microbiome in smoldering multiple myeloma | — | Milan, Milano and 4 other locations | Recruiting | Jul 17, 2025 |
| Identifying precancerous multiple myeloma in African American adults | — | Charlotte, North Carolina | Recruiting | Oct 16, 2024 |
| Testing linvoseltamab for eliminating abnormal plasma cells in patients with high-risk MGUS or smoldering multiple myeloma | Phase 2 | Baltimore, Maryland and 38 other locations | Recruiting | Nov 20, 2023 |
All recruiting trials (4)
-
Multi-omics profiling to predict progression from MGUS and smoldering myeloma to symptomatic multiple myeloma
This project will try to see if combined genomic, immune, and oral microbiome tests can predict which people with MGUS or smoldering myeloma will progress to symptomatic multiple myeloma.
-
Plant-based, high-fiber diets and the gut microbiome in smoldering multiple myeloma
This 12-week program will try a high-fiber plant-based diet in people with smoldering multiple myeloma to see if it changes gut bacteria and raises short-chain fatty acids.
-
Identifying precancerous multiple myeloma in African American adults
This study is testing a way to find early signs of multiple myeloma in Black and African American adults aged 30 and older to help catch it sooner and improve their health outcomes.
-
Testing linvoseltamab for eliminating abnormal plasma cells in patients with high-risk MGUS or smoldering multiple myeloma
This study is testing if a new drug called linvoseltamab can help get rid of abnormal plasma cells in patients with high-risk MGUS or smoldering multiple myeloma.
Related topics
Quick answers
How many Smoldering Multiple Myeloma (SMM) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Italy (3 trials), United States (2 trials), Belgium (1 trial), France (1 trial), Ireland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.